Scientific Programme

Sunday | Monday | Tuesday | Wednesday

 

Sunday, April 22

   
  08:30-10:00
  Clinical Focus Session
CF 101 Colorectal cancer in 2018
   
101.1
101.2
101.3
101.4
101.5
101.6
Tumour biomarkers and metastatic colorectal cancer
Treatment strategies according to the ESMO guidelines
Immunotherapy in metastatic colorectal cancer: present and future
Scientific paper
Local treatment in oligometastatic disease: current role
Intra-arterial therapies in liver dominant disease
   
   
  10:30-12:00
  Clinical Focus Session
CF 201 Immunotherapy: how does it work
   
201.1
201.2
201.3
201.4
201.5
201.6
Tumour micro-environment
Not all cancers are candidates for immunotherapy: why?
T-cell therapy: what you need to know
Scientific paper
Tumour vaccination: local vs. systemic
Radiation and immunotherapy
   
   
  10:30-12:00
  Technical Focus Session
TF 202 Image guidance: case-based discussion
   
202.1
202.2
202.3
202.4
202.5
202.6
Ultrasound: current and future development
CBCT applications: vascular and non-vascular
Combined angio and CT
MR and PET in IO
Robotic and stereotaxic assistance in IO
Hybrid rooms for IO?
   
   
  10:30-12:00
  Hands-on Device Training
TA-HDT 1 Tumour ablation - Radiofrequency
   
   
  13:00-14:30
  Satellite Symposia
   
   
  15:00-16:30
  Clinical Focus Session
CF 401 Colorectal cancer: role of locoregional therapies
   
401.1
 
401.2
401.3
401.4
401.5
401.6
The oncologist's point of view: intra-arterial therapies - when, how and what
to expect
Combined analysis of the global FOXFIRE studies
Scientific paper
Hepatic arterial infusion chemotherapy (HAIC): what are the indications?
What is the role of thermal ablation after the CLOCC trial?
The role of ablation in extrahepatic metastasis
   
   
  15:00-16:30
  Clinical Focus Session
CF 402 Recent developments
   
402.1
402.2
402.3
402.4
402.5
402.6
Drug-eluting particles
Drug delivery and HIFU
Dosimetry in radioembolisation
Scientific paper
Intratumoural viral therapy
Immunotherapy plus ablation or DEB-TACE
   
   
  15:00-16:30
  Hands-on Device Training
TA-HDT 2 Tumour ablation - Radiofrequency
   
   
  17:00-18:30
  Clinical Focus Session
CF 501 Neuroendocrine liver metastases
   
501.1
501.2
501.3
501.4
501.5
Demographics, epidemiology, clinical presentation
Patient selection for local therapies
Radionuclide imaging and therapy in neuroendocrine tumours (Theranostics)
Transarterial therapy: chemoembolisation and bland embolisation
Transarterial therapy: radioembolisation
   
   
  17:00-18:30
  Technical Focus Session
TF 502 Tips and tricks: case-based discussion
   
502.1
502.2
502.3
502.4
502.5
Kidney cancer: central disease
Lung insufficiency and primary cancer
Peripheral liver tumours
Focal prostate ablation: avoiding rectal injury
Pelvic bone ablation: how to avoid neurological complications
   
   
  17:00-19:00
  Basic Course
BC 503 MSK in oncology: Fundamentals of IO in bone and image-guided biopsy
   
   
  18:30-19:00
  Satellite Symposia
   
TOP  
   
   
Monday, April 23
   
  07:45-08:15
  Satellite Symposia
   
   
  08:30-10:00
  Clinical Focus Session
CF 801 Intrahepatic cholangiocarcinoma
   
801.1
801.2
801.3
801.4
801.5
Demographics, epidemiology, clinical presentation and genetics
How to choose among the various liver-directed treatments
Presurgical management: increasing the future remnant liver
Percutaneous ablation in cirrhotic and non-cirrhotic patients
Intra-arterial therapies: the evidence
   
   
  08:30-10:00
  Clinical Focus Session
CF 802 Understanding tumour biology
   
802.1
802.2
802.3
802.4
802.5
802.6
Hypoxia and anoxia – friend or enemy?
Local procedures inducing tumour spread
Scientific paper 
Post-ablation inflammation and immune reactions – the good
Post-ablation inflammation and immune reactions – the bad
Combined locoregional and systemic immunotherapy: clinical results
   
   
  10:30-11:30
HL 901 Honorary Lecture
   
   
  10:30-12:00
  Hands-on Device Training
TA-HDT 3 Tumour ablation - Microwave
   
   
  11:30-12:00
FP 902 Free Paper Session
   
   
  13:00-14:30
  Satellite Symposia
   
   
  15:00-16:30
  Clinical Focus Session
CF 1101 Lung metastases
   
1101.1
1101.2
1101.3
1101.4
1101.5
1101.6
Rationale for local treatment
SBRT: current evidence?
Rationale for thermal ablation
Scientific paper 
Technical considerations of thermal ablation
Clinical and imaging follow-up
   
   
  15:00-16:30
  Clinical Focus Session
CF 1102 HCC in 2018
   
1102.1
1102.2
1102.3
1102.4
1102.5
1102.6
1102.7
HCC classifications: a reappraisal
Hep. B and Hep. C: where to use antiviral therapy in HCC
Local ablation: which technology
Intermediate stage: when radioembolisation should come first?
Scientific paper 
Intermediate stage: what are the indications for combined IO therapies?
Immuno-oncology: future directions for HCC
   
   
  15:00-16:30
  Hands-on Device Training
TA-HDT 4 Tumour ablation - Microwave
   
   
  17:00-18:30
  Clinical Focus Session
CF 1201 IO in HCC: clinical practice
   
1201.1
1201.2
1201.3
1201.4
1201.5
1201.6
Diagnostic imaging of HCC
Added value of biopsy
TACE: a critical appraisal of clinical results
Scientific paper 
New techniques in TACE
Radioembolisation: what has changed with the recent trials?
   
   
  17:00-18:30
  Multidisciplinary Tumour Board
MTB 1202 Primary lung cancer and metastases
   
   
  17:00-19:00
  Basic Course
BC 1203 MSK in oncology: Percutaneous ablation of bone and soft tissue lesions
   
   
  18:30-19:00
  Satellite Symposia
   
TOP  
   
   
Tuesday, April 24
   
  07:45-08:15
  Satellite Symposia
   
   
  08:30-10:00
  Multidisciplinary Tumour Board
MTB 1501 Kidney cancer
   
   
  08:30-10:00
  Clinical Focus Session
CF 1502 Immunotherapy in 2018
   
1502.1
1502.2
 
1502.3
1502.4
1502.5
 
1502.6
Immunoscore: is it more relevant than TNM?
Targeting immunogenic cell death with conventional anticancer therapies: are all equally effective? 
Gene therapy and interventional oncology: searching for synergism
Scientific paper
Local expression of immunostimulating antibodies in the tumour micro-environment: myth or reality? 
Adoptive cell therapy in cancer: a review of clinical applications
   
   
  10:30-12:00
  Clinical Focus Session
CF 1601 MSK: curative treatment
   
1601.1
1601.2
1601.3
1601.4
1601.5
1601.6
Diagnostic imaging and role of biopsy
Bone tumour ablation: which technique and where?
Avoiding neurological complications during ablation
Scientific paper
Embolisation combined with ablation: when and where?
Bone consolidation technique: which technique and where?
   
   
  10:30-12:00
  Clinical Focus Session
CF 1602 Safety belts and airbags: complications and how to avoid them
   
1602.1
1602.2
1602.3
1602.4
1602.5
1602.6
Liver thermal ablation
TACE
Radioembolisation
Kidney ablation
Lung ablation
Pancreatic ablation
   
   
  10:30-12:00
  Hands-on Device Training
TA-HDT 5 Tumour ablation - Cryoablation and laser ablation
   
   
  13:00-14:30
  Satellite Symposia
   
   
  15:00-16:30
  Clinical Focus Session
CF 1801 MSK: palliative treatment
   
1801.1
1801.2
1801.3
1801.4
1801.5
1801.6
Systemic management of pain
IO or SBRT: when and where
Thermal ablation: with or without consolidation
Scientific paper
Embolisation in pain palliation
Percutaneous consolidations: cement, screw …
   
   
  15:00-16:30
  Video Learning Session
VL 1802 How I do it
   
1802.1
1802.2
1802.3
1802.4
1802.5
1802.6
1802.7
1802.8
Lung ablation: anaesthesia and positioning
Multipolar ablation of the liver
Liver radioembolisation in central tumours
Combined techniques: ablation and embolisation
Hilar cholangiocarcinoma: preparation for surgery
Chemosaturation
Tricky bone biopsy
Pancreatic electroporation
   
   
  15:00-16:30
  Hands-on Device Training
TA-HDT 6 Tumour ablation - Image guidance
   
   
  17:00-18:30
  Clinical Focus Session
CF 1901 Follow-up imaging after intervention: towards consensus
   
1901.1
1901.2
1901.3
1901.4
1901.5
 
 
Evidence and current practice in thermal ablation for liver metastasis
Evidence and current practice in TACE for liver cancer
Evidence and current practice in TARE for liver cancer
Evidence and current practice in thermal ablation for lung cancer
Evidence and current practice in thermal ablation for renal cancer
Panel discussion
Conclusions from the expert panel and further directions for clinical practice
   
   
  17:00-18:30
FP 1902 Free Paper Session
   
   
  17:00-19:00
  Basic Course
BC 1903
 
MSK in oncology: Spinal intervention: interventions in vertebral body compression fractures (VBCF)
   
   
  18:30-19:00
  Satellite Symposia
   
TOP  
   
   
Wednesday, April 25
   
  08:30-10:00
  Clinical Focus Session
CF 2101 Kidney tumours
   
2101.1
2101.2
2101.3
2101.4
2101.5
2101.6
Guidelines: EAU, ESMO, CIRSE arguments
Biopsy in renal ablation: when and how?
Scientific paper
Ablation T1b tumours
Evidence-based ablation vs. resection outcomes
Adrenal metastasis ablation
   
   
  08:30-10:00
  Clinical Focus Session
CF 2102
 
The role of local tumour treatment in oligometastatic disease: time for an honest conversation
   
2102.1
2102.2
2102.3
2102.4
2102.5
2102.6
Oligometastatic disease: does it exist?
Which patients should receive systemic therapy?
Local tumour treatment: the role of the surgeon
Interventional oncology: how I select my patients
SABR, conventional radiotherapy or nothing at all – which choice when?
Panel discussion
   
   
  10:00-10:45
  Satellite Symposia
   
   
  11:15-12:45
MM 2201 Morbidity & Mortality Conference
   

TOP